Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis.
Publication
, Journal Article
Lim, HW; Anderson, TF; Douglass, M; Koo, J; Lebwohl, M; Morison, W; Taylor, C; Zanolli, M
Published in: Arch Dermatol
June 1999
Duke Scholars
Published In
Arch Dermatol
DOI
ISSN
0003-987X
Publication Date
June 1999
Volume
135
Issue
6
Start / End Page
717 / 718
Location
United States
Related Subject Headings
- Ultraviolet Therapy
- Psoriasis
- Methotrexate
- Humans
- Dermatology & Venereal Diseases
- Dermatologic Agents
- Cost-Benefit Analysis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lim, H. W., Anderson, T. F., Douglass, M., Koo, J., Lebwohl, M., Morison, W., … Zanolli, M. (1999). Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis. Arch Dermatol, 135(6), 717–718. https://doi.org/10.1001/archderm.135.6.717
Lim, H. W., T. F. Anderson, M. Douglass, J. Koo, M. Lebwohl, W. Morison, C. Taylor, and M. Zanolli. “Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis.” Arch Dermatol 135, no. 6 (June 1999): 717–18. https://doi.org/10.1001/archderm.135.6.717.
Lim HW, Anderson TF, Douglass M, Koo J, Lebwohl M, Morison W, et al. Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis. Arch Dermatol. 1999 Jun;135(6):717–8.
Lim, H. W., et al. “Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis.” Arch Dermatol, vol. 135, no. 6, June 1999, pp. 717–18. Pubmed, doi:10.1001/archderm.135.6.717.
Lim HW, Anderson TF, Douglass M, Koo J, Lebwohl M, Morison W, Taylor C, Zanolli M. Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis. Arch Dermatol. 1999 Jun;135(6):717–718.
Published In
Arch Dermatol
DOI
ISSN
0003-987X
Publication Date
June 1999
Volume
135
Issue
6
Start / End Page
717 / 718
Location
United States
Related Subject Headings
- Ultraviolet Therapy
- Psoriasis
- Methotrexate
- Humans
- Dermatology & Venereal Diseases
- Dermatologic Agents
- Cost-Benefit Analysis
- 1103 Clinical Sciences